LLY and GILD Related Headlines
Go Back- Barclays launches U.S. biopharma coverage with four preferred picks
- Trump to announce prescription drug price agreements
- Bernstein on AmericasMedicines.com: 'The Noise Starts, But Not (Yet) from Trump'
- Buy this U.S. large-cap biopharma stock: JPMorgan
- Citi initiates coverage on biotech amid improving sentiment in sector
- Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
